Stocks · News reference

12 Health Care Stocks Moving In Thursday's After-Market Session

Aug 6, 2026, 9:06 PMBenzinga Insights

Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market session. The market value of their outstanding shares is at $3.8 billion. The company's, Q1 earnings came out

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

AMN ARDX CELZ CVRX DOCS HCAT NTRA ORGO PGNY QDEL RCEL RDHL

Source: benzinga
Observed: Aug 6, 2026, 9:06 PM
Checked: Aug 6, 2026, 9:06 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 14, 2026, 12:51 PMBenzinga Newsdesk
Citizens Maintains Market Outperform on AMN Healthcare Services, Raises Price Target to $40
Citizens analyst Constantine Davides maintains AMN Healthcare Services (NYSE:AMN) with a Market Outperform and raises the price target from $36 to $40.
Read original at benzinga
AMN
BenzingaAug 7, 2026, 11:33 PMBenzinga Newsdesk
UBS Maintains Neutral on AMN Healthcare Services, Raises Price Target to $35
UBS analyst A.J. Rice maintains AMN Healthcare Services (NYSE:AMN) with a Neutral and raises the price target from $32 to $35.
Read original at benzinga
AMN
BenzingaAug 7, 2026, 12:41 PMBenzinga Newsdesk
AMN Healthcare Services shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 sales guidance above estimates.
Read original at benzinga
AMN
BenzingaAug 19, 2026, 12:48 PMBenzinga Newsdesk
Wedbush Reiterates Outperform on Ardelyx, Maintains $9 Price Target
Wedbush analyst Laura Chico reiterates Ardelyx (NASDAQ:ARDX) with a Outperform and maintains $9 price target.
Read original at benzinga
ARDX
SEC EDGARAug 17, 2026, 8:05 PMSEC EDGAR
8-K filing — ARDELYX, INC. (ARDX)
Filed: 2026-08-17 AccNo: 0001193125-26-354026 Size: 142 KB Item 8.01: Other Events
Read original at edgar
ARDX
BenzingaAug 17, 2026, 3:55 PMBenzinga Newsdesk
Piper Sandler Maintains Overweight on Ardelyx, Lowers Price Target to $15
Piper Sandler analyst Christopher Raymond maintains Ardelyx (NASDAQ:ARDX) with a Overweight and lowers the price target from $16 to $15.
Read original at benzinga
ARDX

12 Health Care Stocks Moving In Thursday's After-Market Session

Connected markets

Related headlines

Citizens Maintains Market Outperform on AMN Healthcare Services, Raises Price Target to $40

UBS Maintains Neutral on AMN Healthcare Services, Raises Price Target to $35

AMN Healthcare Services shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 sales guidance above estimates.

Wedbush Reiterates Outperform on Ardelyx, Maintains $9 Price Target

8-K filing — ARDELYX, INC. (ARDX)

Piper Sandler Maintains Overweight on Ardelyx, Lowers Price Target to $15